teva

Teva CEO Kåre Schultz at the Tel Aviv Stock Exchange, February 19, 2020
After turbulent years, Teva CEO Schultz forecasts stability

Teva completed its two-year major restructuring plan in 2019, reducing its cost base by over $3 billion and net debt by more than $9b.

19/02/2020
Teva's first ever National Forum for Bio-Innovators gathers in Tel Aviv

Researcher Hila Flayev has for years been conducting research on computational models of the coronavirus structure and interactions it can create.

FROM RIGHT TO LEFT: Teva Naot CEO Michael Iluz, spokesmodel Dana Grotsky and owner Steve Lax
Teva Naot launches store in Vancouver, Canada

In 2019, Teva Naot sold about 100,000 pairs of shoes in its stores and to retailers, and through the website in the Canadian market.

By JERUSALEM POST STAFF
14/01/2020
A building belonging to generic drug producer Teva, Israel's largest company with a market value of
Teva’s proposed settlement could cost drugmaker pennies on the dollar

Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors.

By REUTERS
24/10/2019
Teva shares surge amid hopes of $23 billion opioid claims settlement

Teva stocks also closed up 8.67% on the New York Stock Exchange on Monday amid growing optimism.

22/10/2019
A building belonging to generic drug producer Teva, Israel's largest company with a market value of
Opioid settlement talks fail with Teva, landmark trial expected Monday

After nearly 11 hours of negotiations, Pennsylvania Attorney General Josh Shapiro told reporters it was “profoundly disappointing” that local governments would not go along with a settlement.

By REUTERS
20/10/2019
The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss th
Teva proposes $15 billion deal to settle opioid claims

The proposed settlement comes only days ahead of a landmark federal trial in Cleveland, Ohio, against the company and five drug distributors.

16/10/2019
Employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in nort
Teva joins medical cannabis market with Israel distribution deal

Under the agreement announced Friday, S.L.E. will distribute Canndoc's GMP-approved products to clients in Israel, including hospitals, health maintenance organizations (HMOs) and all pharmacies.

15/09/2019
A building belonging to generic drug producer Teva, Israel's largest company with a market value of
Teva launches generic version of EpiPen for young children

The drugmaker has been struggling with falling prices of generics and faces lawsuits that allege it helped fuel the U.S. opioid addiction epidemic.

By REUTERS
21/08/2019
The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss th
Teva woes continue amid congressional probe, negative outlook

According to the May lawsuit filed by Connecticut Attorney-General William Tong, Teva significantly raised prices on approximately 112 different generic drugs between July 2013 and January 2015.

15/08/2019
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use